November 18, 2025 · Form 4 insider transaction
Groenewald Ferdinand bought 60,000 shares of BIOSIG TECHNOLOGIES INC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
The restricted stock award was granted under the Company's 2023 Equity Incentive Plan as of November 18, 2025 (the "Date of Grant"), based on a closing price of $4.14 per share on such date; the shares vest in full on the one year anniversary of the Date of Grant.